Perspective Therapeutics (CATX) Non-Current Debt (2023 - 2026)

Perspective Therapeutics has disclosed Non-Current Debt across 4 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Non-Current Debt fell 3.57% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $1.5 million (down 3.57% YoY), while the FY2025 annual figure was $1.6 million, down 3.45% from the prior year.
• Non-Current Debt came in at $1.5 million for Q2 2026 at Perspective Therapeutics, down from $1.6 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $1.8 million in Q1 2023 to a low of $1.5 million in Q2 2026.
• Average Non-Current Debt over 4 years is $1.6 million, with a median of $1.6 million recorded in 2024.
• The largest YoY upside for Non-Current Debt was 3.04% in 2024 against a maximum downside of 7.25% in 2024.
• Over 4 years, Non-Current Debt stood at $1.7 million in 2023, then fell by 3.04% to $1.6 million in 2024, then decreased by 3.45% to $1.6 million in 2025, then slipped by 1.85% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $1.5 million in Q2 2026, $1.6 million in Q1 2026, and $1.6 million in Q4 2025.